Chatbot Localization for Life Sciences

Respond to queries faster, more accurately, in any language, and with specialized and customized informative responses.

Get in Touch
Person holding up a chatbot icon

Engage your key stakeholders with conversational AI

Life sciences organizations are increasingly looking for ways to better leverage data to improve the consumer experience. With the majority of the global population conducting research online about products and services they are interested in, now more than ever, chatbots represent a unique opportunity to effectively engage key stakeholder requests with informative and fast responses.

TransPerfect Life Sciences has the experience and expertise to help you reach key stakeholders around the world through language AI support for training conversational AI technology. Our services include generating datasets, annotating unstructured language data to train conversational technology, and, of course, chatbot localization.

Thank

Respond to patient and HCP multilingual queries faster without sacrificing quality

Our expert linguists are experienced in localizing life sciences chatbots to better reach and engage patients, HCPs, and other stakeholders globally in more than 200 languages.

Chatbot Localization for Catalia Health

Read The Case Study ›

Simplify Multilingual Conversational AI

Whether it’s creating a virtual agent to help train employees, enhancing an existing virtual agent to answer consumer queries, or localizing a chatbot to engage a new audience, TransPerfect’s AI division, DataForce, can support your development of specialized chatbots trained in clinical and medical terminology that can easily integrate with your systems. We have a simple recipe for success:

  • Icon Signed

Design:

Prototypes and designs are created and tested, and feedback is collected to implement changes.

  • Icon AI Integrations

Build:

Conversational AI models are developed and integrated with existing systems before defining business logic, including prompt localization.

  • Icon Computer with Charts

Manage:

Chatbots are deployed, modified, and tested across all voice and chat channels to ensure optimal user experience.

  • Icon Lightbulb

Enhance:

Once deployed, quality analysis is conducted to improve accuracy and engagement with automated testing.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Let’s Chat About Your Chatbot Localization Strategy.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for medical affairs teams in reaching global audiences.

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects today’s eCOA capabilities or institutional habit. Paper is often framed as the “gold standard,” yet paper-based patient-reported outcome data can be incomplete, error-prone and difficult to ...

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials
Success Stories

Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...
Blog

Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered

When the EU Clinical Trial Regulation (EU CTR No 536/2014) went live for new submissions on January 31, 2022, it promised to transform how clinical trials are authorized and conducted across Europe: a single submission, one decision, and harmonized oversight. Four years in,...
Webinar

How to Make Your Academy Succeed at Global Scale—Lessons Learned on What Works and What Doesn’t

Most life sciences and MedTech companies launch a corporate academy with strong strategic intent, whether that’s executive sponsorship, a named platform, a dedicated budget, or a curriculum mapped to business goals. After launch, however, these same organizations all too often ...
Webinar

IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays

Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across ...
Webinar

The Missing Link: Why Study Design Makes or Breaks a Clinical Trial

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant at OptiTrial, to explore why study design is so often the overlooked "missing link" in clinical ...
Event

C3 Summit 2026 - London

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...